Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II trial of adipose tissue-derived mesenchymal stem cells for critical chronic lower limb ischemia in non-diabetic patients
2009-013554-32Phase 2Completed
- Sponsor
- Andalusian Progress and Health Public Foundation
- Start
- Jan 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of adipose derived mesenchymal stromal cells in chronic limb-threatening ischemia (CLTI) and arteriosclerosis obliterans (2 arms), sponsored by Andalusian Progress and Health Public Foundation. Primary endpoint: Adverse events and serious adverse events. Started Jan 2010; status: completed.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
chronic limb-threatening ischemia (CLTI)arteriosclerosis obliterans
Beyond the preview
Go deeper on 2009-013554-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013554-32.